Schelto Kruijff
- Nephrology top 2%
- Parathyroid Disorders and Treatments 26
-
- Thyroid Cancer Diagnosis and Treatment 38
- Pituitary Gland Disorders and Treatments 12
- Oncology top 5%
- Cutaneous Melanoma Detection and Management 25
- Surgery top 5%
- Thyroid and Parathyroid Surgery 31
- Intraperitoneal and Appendiceal Malignancies 14
- Emergency Medicine top 5%
- Appendicitis Diagnosis and Management 11
-
- Immunotherapy and Immune Responses 12
- Co-authors
- Harald J. HoekstraRobert J. van GinkelWillemijn Y. van der PlasGooitzen M. van DamEsther BastiaannetMark SywakLeigh DelbridgeBarbara L. van Leeuwen
- Journals
- SHILAP Revista de lepidopterología (3 papers)JNCI Journal of the National Cancer Institute (1 paper)Oncogene (1 paper)
- Partner nations
- NetherlandsAustraliaSweden
In The Last Decade
Schelto Kruijff
128 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 112
- Nephrology 354
- Endocrinology, Diabetes and Metabolism 428
- Oncology 590
- Surgery 764
- Emergency Medicine 116
Countries citing papers authored by Schelto Kruijff
This map shows the geographic impact of Schelto Kruijff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schelto Kruijff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schelto Kruijff more than expected).
Fields of papers citing papers by Schelto Kruijff
This network shows the impact of papers produced by Schelto Kruijff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schelto Kruijff. The network helps show where Schelto Kruijff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Schelto Kruijff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 18 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 7 | |
| 12 | A Novel and Generic Workflow of Indocyanine Green Perfusion Assessment Integrating Standardization and Quantification Toward Clinical Implementation | 2021 | 13 |
| 13 | 2021 | 11 | |
| 14 | 2021 | 7 | |
| 15 | 2021 | 5 | |
| 16 | 2020 | 10 | |
| 17 | 2020 | 6 | |
| 18 | 2019 | 5 | |
| 19 | 2018 | 22 | |
| 20 | 2013 | 35 |
About Schelto Kruijff
Schelto Kruijff is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Oncology, having authored 144 papers that have together received 2.0k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (38 papers), Thyroid and Parathyroid Surgery (31 papers), Parathyroid Disorders and Treatments (26 papers), Cutaneous Melanoma Detection and Management (25 papers), Intraperitoneal and Appendiceal Malignancies (14 papers), Pituitary Gland Disorders and Treatments (12 papers), Immunotherapy and Immune Responses (12 papers) and Appendicitis Diagnosis and Management (11 papers). The work is most often cited by research in Nephrology (354 citations), Endocrinology, Diabetes and Metabolism (428 citations) and Oncology (590 citations). Schelto Kruijff has collaborated with scholars based in Netherlands, Australia and Sweden. Frequent co-authors include Harald J. Hoekstra, Robert J. van Ginkel, Willemijn Y. van der Plas, Gooitzen M. van Dam, Esther Bastiaannet, Mark Sywak, Leigh Delbridge, Barbara L. van Leeuwen, Patrick Hemmer and Stan B. Sidhu. Their work appears in journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.